Detection and drug resistance of extended spectrum β-lactamase-producing bacteria
Jianping Zhao
Abstract
Jianping Zhao
Abstract
OBJECTIVE To explore the detection rate and drug resistance of extended spectrum β-lactamase(ESBLs) producing Escherichia coli and Klebsiella pneumoniae so as to guide the clinical treatment.METHODS Bacterial identification,drug susceptibility testing(MIC method) and ESBLs detection were performed with French Merieux VITEK-2 Compact automated bacterial culture and identification device,statistical analysis was performed with Whonet 5.3 software.RESULTS E.coli isolates were mainly from urine,accounting for 59.8%,K.pneumoniae isolates were mainly from sputum,accounting for 73.0%,Acid-producing Klebsiella isolates were mainly from sputum,accounting for 75.0%;of 714 strains of pathogens,there were 220 strains of ESBLs-producing bacteria isolated with the detection rate of 30.8%,among which there were 174 strains of ESBLs-producing E.coli with the detection rate of 35.3%,189 strains of ESBLs-producing K.pneumoniae with the detection rate of 19.0%,and 32 strains of ESBLs-producing Acid-producing Klebsiella with the detection rate of 31.2%;the drug resistance rates of ESBLs-producing E.coli and K.pneumoniae to imipenem was 0,the resistance rates to piperacillin/tazobactam sodium were less than 4.2%;the resistance rates of ESBLs-producing strains were significantly higher than non-ESBLs-producing strains to all of the antibiotics except imipenem,the differences were statistically significant antimicrobial drug was significantly higher than non-ESBLs producing strains,the difference was statistically significant(P0.05).CONCLUSION Detection rate of ESBLs-producing bacteria and drug resistance keep an upward tendency and we should strengthen the monitoring of bacterial resistance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To explore the detection rate and drug resistance of extended spectrum β-lactamase(ESBLs) producing Escherichia coli and Klebsiella pneumoniae so as to guide the clinical treatment.METHODS Bacterial identification,drug susceptibility testing(MIC method) and ESBLs detection were performed with French Merieux VITEK-2 Compact automated bacterial culture and identification device,statistical analysis was performed with Whonet 5.3 software.RESULTS E.coli isolates were mainly from urine,accounting for 59.8%,K.pneumoniae isolates were mainly from sputum,accounting for 73.0%,Acid-producing Klebsiella isolates were mainly from sputum,accounting for 75.0%;of 714 strains of pathogens,there were 220 strains of ESBLs-producing bacteria isolated with the detection rate of 30.8%,among which there were 174 strains of ESBLs-producing E.coli with the detection rate of 35.3%,189 strains of ESBLs-producing K.pneumoniae with the detection rate of 19.0%,and 32 strains of ESBLs-producing Acid-producing Klebsiella with the detection rate of 31.2%;the drug resistance rates of ESBLs-producing E.coli and K.pneumoniae to imipenem was 0,the resistance rates to piperacillin/tazobactam sodium were less than 4.2%;the resistance rates of ESBLs-producing strains were significantly higher than non-ESBLs-producing strains to all of the antibiotics except imipenem,the differences were statistically significant antimicrobial drug was significantly higher than non-ESBLs producing strains,the difference was statistically significant(P0.05).CONCLUSION Detection rate of ESBLs-producing bacteria and drug resistance keep an upward tendency and we should strengthen the monitoring of bacterial resistance.
Key concepts: Klebsiella pneumoniae, Imipenem, Microbiology, Piperacillin, Drug resistance, Tazobactam, Biology, Sputum